Navigation Links
Global Pharmaceuticals & Medicine Manufacturing Industry Market Research Report from IBISWorld has Been Updated

Los Angeles, CA (PRWEB) December 06, 2013

Over the five years to 2013, the Global Pharmaceuticals and Medicine Manufacturing industry enjoyed steady growth, despite a number of changes to the industry's landscape. Industry revenue grew as a result of increased access to more comprehensive healthcare in developing countries and demographic shifts necessitating more healthcare expenditure. “The increasing number of global middle-class individuals has also translated into dramatic increases in demand for pharmaceuticals,” according to IBISWorld Industry Analyst Anna Son. Industry growth has been restrained, however, by the potent combination of a historically high level of patent expirations on blockbuster drugs, accelerating competition from generics and contributing to a depleted product pipeline, with fewer new medicines being marketed. Growing price pressures from governments and health insurance organizations around the globe has also placed significant strain on the industry.

During the five years to 2013, IBISWorld estimates that industry revenue will grow at an average annual rate of 3.7% to total $1.1 trillion. Over this year, the industry will continue to be challenged by key patent expirations and continued pricing pressures, amid changing healthcare access and funding issues. At the same time, emerging markets such as China, India and Brazil, will continue driving sales of pharmaceuticals. “Development in these markets is significantly exceeding the growth rates of more mature markets, such as the United States and Western Europe, which have to contend with increased regulation and significant changes in healthcare policy, due to various austerity measures and healthcare reforms,” says Son. However, despite these obstacles, revenue is forecast to grow 3.4% in 2013 overall.

In the short term, the industry is expected to continue its gradual transformation process. That is to say, emerging markets will continue to grow in importance as the geographic base of the industry gradually moves away from the traditional market powerhouses. Meanwhile, diversification strategies and merger and acquisition activity will remain key features that will characterize the industry's evolution. In addition, large-cap pharmaceutical companies will seek to acquire or partner with biotechnology companies with promising drug candidates, in order to bolster thinning pipelines.

For more information, visit IBISWorld’s Global Pharmaceuticals & Medicine Manufacturing industry report page.

Follow IBISWorld on Twitter:!/IBISWorld
Friend IBISWorld on Facebook:

IBISWorld industry Report Key Topics

This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based (or ethical) products and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on nearly every US and Global industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit or call 1-800-330-3772.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural etc)- Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
2. M3 Global Research Expands Qualitative Research Department- Next Important Step in M3 Group Growth Strategy
3. Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013
4. Special Offer on Pharma Country Reports Bundle by GlobalData Available at
5. BCC Research Publishes A New Report On Global Markets For Reproductive Technologies
6. BioPharm Insight Releases Quarterly Licensing Information on Global Drug Development
7. AMD Global Telemedicine Announces Integration of Encounter Management Software with Patient Records Management System
8. New report illustrates persistent global burden of anemia among high-risk populations
9. Matakina Launches Volumetric Breast Imaging Tools Built upon Globally Used, Multi-Vendor VolparaDensity Volumetric Breast Density Software
10. BCC Research Publishes A New Report On Global Markets For Waste And Wastewater Treatment
11. Hemodialysis Industry for Global and China 2013 Analysis in New Research Report at
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... ... 25, 2015 , ... In an ongoing Clinical Study conducted by an independent ... UV Angel is evaluating the efficacy of its product and its disinfection protocol. This ... beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
Breaking Medicine Technology: